Fig. 4.
Fig. 4. RGS18 expression in hematopoietic cells. / The fixed suspension cells isolated from mouse bone marrow (A) and the fixed section of mouse spleen (B) were stained with anti-RGS18 rat antibody followed by Cy3-conjugated F(ab′)2 fragment goat antirat antibody, together with DAPI. RGS18 is seen in red and chromosomes are seen in blue. The Hoechst−Rhodamine− cells/SP cells as hematopoietic stem cells (C), Ly-6G/Gr-1+ or CD11b/Mac-1+ cells as granulocyte and monocyte mix (D), and TER-119+ cells as erythrocyte and megakaryocyte mix (E, F) were isolated from mouse bone marrow by fluorescence-activated cell sorting and were immunostained with a purified FITC-labeled anti-RGS18 antibody (C-E). The TER-119+ cells were stained with FITC-labeled anti-RGS18 antibody (E) and with DAPI (F).

RGS18 expression in hematopoietic cells.

The fixed suspension cells isolated from mouse bone marrow (A) and the fixed section of mouse spleen (B) were stained with anti-RGS18 rat antibody followed by Cy3-conjugated F(ab′)2 fragment goat antirat antibody, together with DAPI. RGS18 is seen in red and chromosomes are seen in blue. The HoechstRhodamine cells/SP cells as hematopoietic stem cells (C), Ly-6G/Gr-1+ or CD11b/Mac-1+ cells as granulocyte and monocyte mix (D), and TER-119+ cells as erythrocyte and megakaryocyte mix (E, F) were isolated from mouse bone marrow by fluorescence-activated cell sorting and were immunostained with a purified FITC-labeled anti-RGS18 antibody (C-E). The TER-119+ cells were stained with FITC-labeled anti-RGS18 antibody (E) and with DAPI (F).

Close Modal

or Create an Account

Close Modal
Close Modal